Cen Biotech Stock Price, News & Analysis
Company Description
Cen Biotech (OTC Link: CENBF) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $6.5K.
CENBF stock has gained 0.0% over the past year. Shares last traded at $0.0001.
This page provides a comprehensive overview of CENBF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Cen Biotech (CENBF) stock last traded at $0.0001. At a market capitalization of $6.5K, CENBF is classified as a micro-cap stock with approximately 65.3M shares outstanding.
Latest News
Cen Biotech has 2 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. Key topics include acquisition. View all CENBF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Cen Biotech (CENBF) currently stands at 46 shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Cen Biotech (CENBF) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
CENBF Company Profile & Sector Positioning
Cen Biotech (CENBF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing CENBF often look at related companies in the same sector, including Wowi (WOWU), Bloomios Inc (BLMS), Mj Holdings (MJNE), CRAFT 1861 (BGPPF), and Avivagen (VIVXF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CENBF's relative position within its industry.